Trial Information

Multicenter Cross Sectional Study of Primary Intestine Lymphoma: Treatment Outcome and Quality of Life

Intestine is the one of commonly involved extranodal sites of non-Hodgkin's lymphoma (NHL).
Thus, small and large Intestine account for approximately 30-40% of primary gastrointestinal
tract lymphoma. More than 70% of intestinal lymphoma presents as localized disease, and
surgery such as bowel resection is performed in many patients with intestinal lymphoma for
diagnosis and treatment. However, it is still unclear whether surgical resection followed by
chemotherapy is superior to systemic chemotherapy alone in terms of treatment outcome and
quality of life (QOL). Thus, we analyze the clinical features and treatment outcome of
patients with NHL of intestine, and at the same time perform a multicenter cross-sectional
study about the QOL in survivors of intestine NHL. We evaluates the treatment outcomes of
patients with intestine NHL from hospitals affiliated with the Consortium for Improving
Survival of Lymphoma (CISL) in Korea. We assess the QOL of survivors who completed their
treatment using the EORTC QLQ-C30 questionnaire.